This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Journal:Molecular Cell:2
From Proteopedia
(Difference between revisions)

| Line 7: | Line 7: | ||
The focal point of our study was the phosphotriesterase (PTE) from ''Pseudomonas diminuta''. PTE is a promiscuous metalloenzyme: in addition to highly efficient hydrolysis of the organophosphate pesticide paraoxon (k<sub>cat</sub>/K<sub>M</sub> approximately 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>), it promiscuously hydrolyzes esters, lactones, and diverse organophosphates, including toxic nerve agents, such as VX, Russian VX, soman (GD), and cyclosarin (GF), albeit with k<sub>cat</sub>/K<sub>M</sub> values that are orders-of-magnitude lower than for paraoxon. Effective organophosphate detoxification, however, demands high catalytic efficiency, with k<sub>cat</sub>/K<sub>M</sub> of 10<sup>7</sup> M<sup>-1</sup>min<sup>-1</sup> considered a minimum for ''in vivo'' protection, thereby motivating several recent enzyme-engineering efforts that targeted PTE. Furthermore, the growing threat from a new generation of nerve agents, similar in structure to VX and GF, emphasizes the need for broad-spectrum nerve-agent hydrolases. FuncLib’s goal is to design a small set of stable, efficient,and functionally diverse multipoint active-site mutants suitable for low-throughput experimental testing. The design strategy is general and can be applied, in principle, to any natural enzyme starting from its molecular structure and adiverse set of homologous sequences. | The focal point of our study was the phosphotriesterase (PTE) from ''Pseudomonas diminuta''. PTE is a promiscuous metalloenzyme: in addition to highly efficient hydrolysis of the organophosphate pesticide paraoxon (k<sub>cat</sub>/K<sub>M</sub> approximately 10<sup>8</sup> M<sup>-1</sup>s<sup>-1</sup>), it promiscuously hydrolyzes esters, lactones, and diverse organophosphates, including toxic nerve agents, such as VX, Russian VX, soman (GD), and cyclosarin (GF), albeit with k<sub>cat</sub>/K<sub>M</sub> values that are orders-of-magnitude lower than for paraoxon. Effective organophosphate detoxification, however, demands high catalytic efficiency, with k<sub>cat</sub>/K<sub>M</sub> of 10<sup>7</sup> M<sup>-1</sup>min<sup>-1</sup> considered a minimum for ''in vivo'' protection, thereby motivating several recent enzyme-engineering efforts that targeted PTE. Furthermore, the growing threat from a new generation of nerve agents, similar in structure to VX and GF, emphasizes the need for broad-spectrum nerve-agent hydrolases. FuncLib’s goal is to design a small set of stable, efficient,and functionally diverse multipoint active-site mutants suitable for low-throughput experimental testing. The design strategy is general and can be applied, in principle, to any natural enzyme starting from its molecular structure and adiverse set of homologous sequences. | ||
| + | |||
| + | <scene name='79/793845/Cv/2'>The wild type PTE active site</scene> (PDB entry [[1hzy]]) comprises a bimetal center, typically of <font color='gray'><b>Zn<sup>2+</sup> ions (gray spheres)</b></font>, which are liganded by <span style="color:orange;background-color:black;font-weight:bold;">highly conserved residues (orange)</span>. <font color='red'><b>Water molecules are shown as red spheres</b></font>. <scene name='78/789383/Cv/6'>Eight additional residues</scene> <font color='magenta'><b>(magenta) comprise the active-site wall and are less conserved</b></font>. FuncLib starts by filtering single-point mutations according to evolutionary-conservation and atomistic-stability analyses, resulting in a subset of potentially tolerated mutations: | ||
<b>References</b><br> | <b>References</b><br> | ||
<references/> | <references/> | ||
</StructureSection> | </StructureSection> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ | ||
Revision as of 12:09, 9 August 2018
| |||||||||||
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
